Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) EV to CFO (2010 - 2026)

Lite Strategy (LITS) posted EV to CFO of 21.87 for Q1 2026, down 7.49% on a QoQ basis from 20.34 in Q4 2025, and down 1309.16% year-over-year from 1.81 in Q1 2025.

Analysis

Lite Strategy (LITS) EV to CFO (2010 - 2026) Analysis & Trends

Lite Strategy has reported EV to CFO for 17 years, with the latest figure at 21.87 in Q1 2026.

  • On a quarterly basis, EV to CFO fell 1309.16% year-over-year to 21.87 in Q1 2026; TTM through Mar 2026 was 3.19, a 2064.63% decrease from a year earlier, with the FY2025 full-year figure at 0.07, down 80.16% from the prior year.
  • EV to CFO was 21.87 for Q1 2026 at Lite Strategy, down from 20.34 in the prior quarter.
  • The five-year high for EV to CFO was 28.74 in Q1 2024, with the low at 21.87 in Q1 2026.
  • Average EV to CFO over 5 years is 3.64, with a median of 4.65 recorded in 2022.
  • The sharpest annual moves came in 2022 and 2026: EV to CFO jumped 2912.52% in 2022, then tumbled 1309.16% in 2026.
  • Over 5 years, EV to CFO stood at 14.4 in 2022, then sank by 52.79% to 6.8 in 2023, then sank by 70.52% to 2.0 in 2024, then tumbled by 1114.89% to 20.34 in 2025, then retreated by 7.49% to 21.87 in 2026.
  • The last three EV to CFO figures came in at 21.87 (Q1 2026), 20.34 (Q4 2025), and 13.58 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.87
Dec 31, 2025 -20.34
Sep 30, 2025 -13.58
Jun 30, 2025 0.63
Mar 31, 2025 1.81
Dec 31, 2024 2.00
Sep 30, 2024 2.44
Jun 30, 2024 1.05
Mar 31, 2024 28.74
Dec 31, 2023 6.80
Sep 30, 2023 6.18
Jun 30, 2023 5.03
Mar 31, 2023 15.22
Dec 31, 2022 14.40
Sep 30, 2022 14.21
Jun 30, 2022 4.65
Mar 31, 2022 14.57
Dec 31, 2021 0.48
Sep 30, 2021 -4.61
Jun 30, 2021 -2.01